Coronavirus Latest News

Chinese drug makers want to produce US Covid-19 pill for poorer nations

Chinese firms have expressed an interest in producing an experimental Covid-19 drug developed by US pharmaceutical companies Merck and Ridgeback Biotherapeutics – under a global programme for their distribution in developing countries.The UN-backed Medicines Patent Pool (MPP) recently reached an agreement with Merck to grant sublicences for other pharmaceutical firms to produce generic versions of the experimental molnupiravir antiviral pill, for supply to 105 middle- and low-income countries…

Read the original article at South China Morning Post

Related Articles

Back to top button